2-Plaintiff Cymbalta Withdrawal Trial To Get Under Way Aug. 24 In Virginia
Gilda Hagan-Brown says she was prescribed Cymbalta in September 2012 to treat fibromyalgia and osteoarthritis. In March 2013, she wanted to wean herself off Cymbalta because it left her feeling intoxicated.
Hagan-Brown said she experienced withdrawal symptoms including suicidal thoughts, severe depression, migraines, “buzzing” in her...
To view the full article, register now.